ConductScience.org, home

Paper19821373

Cannabinoids for Tourette's Syndrome.

Curtis A and 2 others. Cochrane Database Syst Rev, 2009. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Cannabinoids for Tourette's Syndrome. Papers, record 19821373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821373

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cannabinoids for Tourette's Syndrome.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2009
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2025-06-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Curtis AAdrienne
2Clarke CECarl E
3Rickards HEHugh E

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CannabinoidsMajor topic
Tourette SyndromeMajor topic
Dronabinol
Humans
Randomized Controlled Trials as Topic

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111865128Treatment of ADHD in children with tics: a randomized controlled trial.Neurology2002https://conductscience.org/library/papers/11865128PubMed
22665687Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.Arch Gen Psychiatry1989https://conductscience.org/library/papers/2665687PubMed
311157424Psychiatric effects of cannabis.Br J Psychiatry2001https://conductscience.org/library/papers/11157424PubMed
412716250Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.J Clin Psychiatry2003https://conductscience.org/library/papers/12716250PubMed
51592779The validity of instruments measuring tic severity in Tourette's syndrome.J Am Acad Child Adolesc Psychiatry1992https://conductscience.org/library/papers/1592779PubMed
611886028Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.J Am Acad Child Adolesc Psychiatry2002https://conductscience.org/library/papers/11886028PubMed
711951146Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.Pharmacopsychiatry2002https://conductscience.org/library/papers/11951146PubMed
87689702Molecular characterization of a peripheral receptor for cannabinoids.Nature1993https://conductscience.org/library/papers/7689702PubMed
912849183The therapeutic potential of cannabis.Lancet Neurol2003https://conductscience.org/library/papers/12849183PubMed
108912803A community survey of adverse effects of cannabis use.Drug Alcohol Depend1996https://conductscience.org/library/papers/8912803PubMed
112136063Treatment of Tourette's syndrome with transdermal clonidine: a pilot study.J Neuropsychiatry Clin Neurosci1990https://conductscience.org/library/papers/2136063PubMed
1212182961The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.Pharmacol Ther2002https://conductscience.org/library/papers/12182961PubMed
1322291003Effective treatment of Tourette's syndrome with marijuana.J Psychopharmacol1993https://conductscience.org/library/papers/22291003PubMed
142165569Structure of a cannabinoid receptor and functional expression of the cloned cDNA.Nature1990https://conductscience.org/library/papers/2165569PubMed
156371107Controlled study of pimozide vs. placebo in Tourette's syndrome.J Am Acad Child Psychiatry1984https://conductscience.org/library/papers/6371107PubMed
168440779Localization of cannabinoid receptor mRNA in rat brain.J Comp Neurol1993https://conductscience.org/library/papers/8440779PubMed
1711235929Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.J Clin Psychiatry2001https://conductscience.org/library/papers/11235929PubMed
1811229617Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.Pharmacopsychiatry2001https://conductscience.org/library/papers/11229617PubMed
1911323066The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.Lancet2001https://conductscience.org/library/papers/11323066PubMed
2012589392Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.Neuropsychopharmacology2003https://conductscience.org/library/papers/12589392PubMed

See all 27 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42658450Ovarian ageing: from biological constraint to emerging therapeutic frontier.J Assist Reprod Genet2026https://conductscience.org/library/papers/42658450PubMed
42512092Chronic Δ9-Tetrahydrocannabinol Inhalation Following Osteoporosis Results in Bone Deficits.Biomedicines2026https://conductscience.org/library/papers/42512092PubMed
40777575A narrative review to guide treatment and care for children with Tourette syndrome.Brain Disord2023https://conductscience.org/library/papers/40777575PubMed
38985199Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis.Eur J Clin Pharmacol2024https://conductscience.org/library/papers/38985199PubMed
36864363Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review.Eur Child Adolesc Psychiatry2024https://conductscience.org/library/papers/36864363PubMed
35859051Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review.J Neural Transm (Vienna)2022https://conductscience.org/library/papers/35859051PubMed
35401364The Efficacy of Cognitive Behavioral Therapy for Tic Disorder: A Meta-Analysis and a Literature Review.Front Psychol2022https://conductscience.org/library/papers/35401364PubMed
35107785Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.Curr Neurol Neurosci Rep2022https://conductscience.org/library/papers/35107785PubMed
34436650Chronic ∆-9-tetrahydrocannabinol administration delays acquisition of schedule-induced drinking in rats and retains long-lasting effects.Psychopharmacology (Berl)2022https://conductscience.org/library/papers/34436650PubMed
34430070Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray.Tremor Other Hyperkinet Mov (N Y)2021https://conductscience.org/library/papers/34430070PubMed
32856174Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments.Neurotherapeutics2020https://conductscience.org/library/papers/32856174PubMed
32656342The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?Cannabis Cannabinoid Res2019https://conductscience.org/library/papers/32656342PubMed
32641910A Review of the Current Treatment of Tourette Syndrome.J Pediatr Pharmacol Ther2020https://conductscience.org/library/papers/32641910PubMed
32020875Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews.BMC Complement Med Ther2020https://conductscience.org/library/papers/32020875PubMed
31955299Treatment of tics associated with Tourette syndrome.J Neural Transm (Vienna)2020https://conductscience.org/library/papers/31955299PubMed
31823819Benefits and harms of medical cannabis: a scoping review of systematic reviews.Syst Rev2019https://conductscience.org/library/papers/31823819PubMed
30977108The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.CNS Drugs2019https://conductscience.org/library/papers/30977108PubMed
30365598What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice?Sao Paulo Med J2018https://conductscience.org/library/papers/30365598PubMed
30090843Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration.Int J Phys Med Rehabil2018https://conductscience.org/library/papers/30090843PubMed
30072700Striatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies.Transl Psychiatry2018https://conductscience.org/library/papers/30072700PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19821373

GET https://conductscience.org/api/papers/v1/19821373/references?page=2